Pilot Study of Appropriate Dosing for Reducing and Removing Hyaluronic Acid Filler With Hyaluronidase: A Randomized Control Clinical Trial

STU68166

The purpose of this study is to find how much hyaluronidase should be used when receiving injections of fillers.

2012-10-01

2024-12-01

2024-12-01

Active (not recruiting)

Early phase I

5

Inclusion Criteria: * Age 18 and over * The subjects are in good health * The subject has the willingness and the ability to understand and provide informed consent for the use of their tissue and communicate with the investigator Exclusion Criteria: * Under 18 years of age * Pregnancy or Lactation * Subjects who are unable to understand the protocol or to give informed consent * Subjects with mental illness * Recent Accutane use in the past 6 months * Subjects prone to hypertrophic and keloidal scarring * Subjects with tattoos and/or scars on upper medial arms (the treatment area) * Subjects with known hypersensitivity to hyaluronic acid

{'studyType': 'INTERVENTIONAL', 'phases': ['EARLY_PHASE1'], 'designInfo': {'allocation': 'NA', 'interventionModel': 'SINGLE_GROUP', 'primaryPurpose': 'BASIC_SCIENCE', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 5, 'type': 'ESTIMATED'}}

2024-02-05